Two barriers for sodium in vascular endothelium?

Annals of Medicine

Volumn 44, Issue SUPPL. 1, 2012, Pages

  Oberleithner, Hans ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Aldosterone; atomic force microscopy; endothelial dysfunction; endothelial glycocalyx; epithelial sodium channel; hypertension; mechanical stiffness; salt intake; spironolactone; stiff endothelial cell syndrome

Indexed keywords

ALDOSTERONE; BIOPOLYMER; CALCIUM; EPLERENONE; PROTEOGLYCAN; SODIUM; SODIUM CHANNEL;

BLOOD PRESSURE REGULATION; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DETERIORATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL GLYCOCALYX; ENDOTHELIUM CELL; GLYCOCALYX; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FIBROSIS; MEASUREMENT; MODEL; PRIORITY JOURNAL; SHORT SURVEY; SODIUM BALANCE; SODIUM BLOOD LEVEL; SODIUM INTAKE; STIFF ENDOTHELIAL CELL SYNDROME; STROKE; SURFACE PROPERTY; UPREGULATION; URINARY EXCRETION; VASCULAR ENDOTHELIUM;

BLOOD PRESSURE; ENDOTHELIUM, VASCULAR; GLYCOCALYX; HOMEOSTASIS; HUMANS; PERMEABILITY; SODIUM; SODIUM CHANNELS;

EID: 84862528010     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2011.653397     Document Type: Short Survey

References (43)

1. Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol. 2003;284:R1-12.
2. Fels J, Callies C, Kusche-Vihrog K, Oberleithner H. Nitric oxide release follows endothelial nanomechanics and not vice versa. Pflugers Arch. 2010;460:419-23.
3. Jonas M, So PT, Huang H. Cell mechanics at multiple scales. Methods Enzymol. 2008;443:177-98.
4. Kliche K, Jeggle P, Pavenstadt H, Oberleithner H. Role of cellular mechanics in the function and life span of vascular endothelium. Pflugers Arch. 2011;462:209-17.
5. Bussemaker E, Hillebrand U, Hausberg M, Pavenstadt H, Oberleithner H. Pathogenesis of hypertension: interactions among sodium, potassium, and aldosterone. Am J Kidney Dis. 2010;55:1111-20.
6. Binnig G, Quate CF, Gerber C. Atomic force microscope. Phys Rev Lett. 1986;56:930-4.
7. Kasas S, Dietler G. Probing nanomechanical properties from biomolecules to living cells. Pflugers Arch. 2008;456: 13-27.
8. Oberleithner H, Callies C, Kusche-Vihrog K, Schillers H, Shahin V, Riethmuller C, et al. Potassium softens vascular endothelium and increases nitric oxide release. Proc Natl Acad Sci USA. 2009;106:2829-34.
9. Radmacher M. Measuring the elastic properties of biological samples with the AFM [see comments]. IEEE Eng Med Biol Mag. 1997;16:47-57. (Pubitemid 27133548)
10. Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev. 2005;85:679-715. (Pubitemid 40404639)
11. Adrogue HJ, Madias NE. Sodium and potassium in the pathogenesis of hypertension. N Engl J Med. 2007;356: 1966-78.
12. Funder JW. Mineralocorticoid receptors and cardiovascular damage: it's not just aldosterone. Hypertension. 2006;47: 634-5. (Pubitemid 43740226)
13. He FJ, Marciniak M, Markandu ND, Antonios TF, MacGregor GA. Effect of modest salt reduction on skin capillary rarefaction in white, black, and Asian individuals with mild hypertension. Hypertension. 2010;56:253-9.
14. Ritz E. Salt - friend or foe? Nephrol Dial Transplant. 2006;21:2052-6. (Pubitemid 44295024)
15. Sanders PW. Vascular consequences of dietary salt intake. Am J Physiol Renal Physiol. 2009;297:F237-43.
16. Lang F. Stiff endothelial cell syndrome in vascular inflammation and mineralocorticoid excess. Hypertension. 2011;57: 146-7.
17. Kusche-Vihrog K, Urbanova K, Blanque A, Wilhelmi M, Schillers H, Kliche K, et al. C-reactive protein makes human endothelium stiff and tight. Hypertension. 2011;57:231-7.
18. Titze J, Lang R, Ilies C, Schwind KH, Kirsch KA, Dietsch P, et al. Osmotically inactive skin Na+ storage in rats. Am J Physiol Renal Physiol. 2003;285:F1108-17. (Pubitemid 37421047)
19. Titze J, Machnik A. Sodium sensing in the interstitium and relationship to hypertension. Curr Opin Nephrol Hypertens. 2010;19:385-92.
20. Adams JM, Bardgett ME, Stocker SD. Ventral lamina terminalis mediates enhanced cardiovascular responses of rostral ventrolateral medulla neurons during increased dietary salt. Hypertension. 2009;54:308-14.
21. He FJ, Markandu ND, Sagnella GA, de Wardener HE, MacGregor GA. Plasma sodium: ignored and underestimated. Hypertension. 2005;45:98-102. (Pubitemid 40066421)
22. Oberleithner H, Riethmuller C, Schillers H, MacGregor GA, de Wardener HE, Hausberg M. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci USA. 2007;104:16281-6. (Pubitemid 350099397)
23. Singh A, Satchell SC, Neal CR, McKenzie EA, Tooke JE, Mathieson PW. Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J Am Soc Nephrol. 2007;18:2885-93. (Pubitemid 350058395)
24. VanTeeffelen JW, Brands J, Jansen C, Spaan JA, Vink H. Heparin impairs glycocalyx barrier properties and attenuates shear dependent vasodilation in mice. Hypertension. 2007;50:261-7. (Pubitemid 46986050)
25. Weinbaum S, Zhang X, Han Y, Vink H, Cowin SC. Mechanotransduction and flow across the endothelial glycocalyx. Proc Natl Acad Sci USA. 2003;100:7988-95. (Pubitemid 36760082)
26. Tarbell JM, Ebong EE. The endothelial glycocalyx: a mechano-sensor and -transducer. Sci Signal. 2008;1:pt8.
27. Nieuwdorp M, Meuwese MC, Vink H, Hoekstra JB, Kastelein JJ, Stroes ES. The endothelial glycocalyx: a potential barrier between health and vascular disease. Curr Opin Lipidol. 2005;16:507-11. (Pubitemid 41376899)
28. Chappell D, Westphal M, Jacob M. The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness. Curr Opin Anaesthesiol. 2009;22:155-62.
29. Siegel G, Walter A, Kauschmann A, Malmsten M, Buddecke E. Anionic biopolymers as blood flow sensors. Biosens Bioelectron. 1996;11:281-94. (Pubitemid 26042805)
30. Bevan JA. Flow regulation of vascular tone. Its sensitivity to changes in sodium and calcium. Hypertension. 1993;22: 273-81. (Pubitemid 23254073)
31. Oberleithner H, Peters W, Kusche-Vihrog K, Korte S, Schillers H, Kliche K, et al. Salt overload damages the glycocalyx sodium barrier of vascular endothelium. Pflugers Arch. 2011;462:519-28.
32. Kusche-Vihrog K, Sobczak K, Bangel N, Wilhelmi M, Nechyporuk-Zloy V, Schwab A, et al. Aldosterone and amiloride alter ENaC abundance in vascular endothelium. Pflugers Arch. 2008;455:849-57. (Pubitemid 350265623)
33. Golestaneh N, Klein C, Valamanesh F, Suarez G, Agarwal MK, Mirshahi M. Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton. Biochem Biophys Res Commun. 2001;280:1300-6. (Pubitemid 32917785)
34. Chen W, Valamanesh F, Mirshahi T, Soria J, Tang R, Agarwal MK, et al. Aldosterone signaling modifies capillary formation by human bone marrow endothelial cells. Vascul Pharmacol. 2004;40:269-77. (Pubitemid 38452711)
35. Pries AR, Secomb TW, Gaehtgens P. The endothelial surface layer. Pflugers Arch. 2000;440:653-66.
36. Potter DR, Jiang J, Damiano ER. The recovery time course of the endothelial cell glycocalyx in vivo and its implications in vitro. Circ Res. 2009;104:1318-25.
37. Chappell D, Jacob M, Paul O, Rehm M, Welsch U, Stoeckelhuber M, et al. The glycocalyx of the human umbilical vein endothelial cell: an impressive structure ex vivo but not in culture. Circ Res. 2009;104:1313-7.
38. Korte S, Wiesinger A, Strater AS, Peters W, Oberleithner H, Kusche-Vihrog K. Firewall function of the endothelial glycocalyx in the regulation of sodium homeostasis. Pflugers Arch. 2012;463:269-78.
39. Peters W, Druppel V, Kusche-Vihrog K, Schubert C, Oberleithner H. Nanomechanics and sodium permeability of the endothelial surface layer modulated by hawthorn extract WS 1442. PLoS One. 2012;7:e29972.
40. Le GA, Gavard J. Role of endothelial cell-cell junctions in endothelial permeability. Methods Mol Biol. 2011;763: 265-79.
41. Komarova Y, Malik AB. Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu Rev Physiol. 2010;72:463-93.
42. Becker BF, Chappell D, Jacob M. Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Basic Res Cardiol. 2010;105:687-701.
43. Waanders F, de Vries LV, van GH, Hillebrands JL, Laverman GD, Bakker SJ, et al. Aldosterone, from (patho)physiology to treatment in cardiovascular and renal damage. Curr Vasc Pharmacol. 2011;9:594-605.